Department of Urogynaecology, Medway Maritime Hospital, Gillingham, Kent ME7 5NY, UK.

This email address is being protected from spam bots, you need Javascript enabled to view it

In October 2006, the National Institute for Health and Clinical Excellence (NICE) released Guideline No. 40: The management of female urinary incontinence. The objective of this study was to investigate the opinions of members of the British Society of Urogynaecology (BSUG) regarding the recommendations contained in the guideline. A closed format questionnaire using stems taken directly from the NICE guideline was sent to all UK-based members of BSUG. There was a 64% response rate. When asked if the guidance overall reflected their current practice, 56.8% agreed/strongly agreed. In terms of changing their practice to comply fully with the guideline, 53.3% disagreed/strongly disagreed. There were two major areas of disagreement. Some 80% of respondents disagreed that preoperative cystometry was not necessary in 'clinically pure' stress urinary incontinence; 72% of respondents disagreed that immediate release oxybutynin should be the first-line treatment for women with an overactive bladder (OAB). A smaller proportion disagreed with the statements on the use of duloxetine. The majority of the guidance formalises current practice among gynaecologists and urogynaecologists practicing in the UK. There are significant concerns regarding some of the recommendations, and the results indicate that over half of the respondents would not change their practice to follow these recommendations.

Written by:
Basu M, Duckett JR, Moran P, Freeman R.   Are you the author?

Reference:
J Obstet Gynaecol. 2009 Aug;29(6):529-32.
doi:10.1080/01443610903003167

PubMed Abstract
PMID:19697203

UroToday.com Infections Section

Please log-in or register in order to submit comments.

Powered by AkoComment!